AdvisorShares Pure US Cannabis ETF (MSOS)

The long-term outlook remains deeply bearish due to a catastrophic multi-year price trajectory, which has erased over 94% of the asset's value since inception. While the business may have improved recently, the market has punished the security relentlessly, dropping from highs of $41 to current levels around $5, a decline that dwarfs any potential recovery narrative. The recent news of cannabis rescheduling offers hope, but the price action suggests investors remain skeptical of immediate value restoration. On the short end, the setup is mixed; while the stock is technically trading above its 50-day moving average, showing some resilience, the overwhelming options activity is defensive. Traders are buying deep out-of-the-money puts to guard against further drops, while call buyers are only betting on a modest rebound to the $6 range. This defensive positioning in the options chain, combined with the lack of a sustained price recovery, keeps the short-term rating neutral. Finally, there is no dividend income to speak of; the security has paid virtually nothing in the last five years, offering zero yield to cushion the losses.